- Fda withdrawn Proxyphene from US market
- The Whistleblower Case
- Medical Crisis in Haiti
- Drug warnings in the news
Fda withdrawn Proxyphene from US market
In November, the US Food and Drug Administration (FDA) pulled propoxyphene, sold under the brand names Darvon and Darvocet by Xanodyne Pharmaceuticals, from the US market. The decision also affected generic manufacturers and the makers of propoxyphene-containing products. New clinical data showed that the drug puts patients at risk for potentially serious or even fatal heart rhythm abnormalities. An estimated 10 million patients have used these products.
